亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Burden of cancer in Africa, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023

医学 癌症 疾病 疾病负担 环境卫生 疾病负担 梅德林 重症监护医学 流行病学 人口 全球卫生
作者
Atalel Fentahun Awedew,Sherief Mohamed Abd-Elsalam,Auwal Abdullahi,Mesfin Abebe,Kedir Hussein Abegaz,Alemwork Abie,Richard Gyan Aboagye,Bilyaminu Abubakar,Rufus Adesoji Adedoyin,Ayman Ahmed,Timothy Olukunle Aladelusi,Mohammed Usman Ali,Hubert Amu,Ganiyu Adeniyi Amusa,Haftu Asmerom,Amlaku Mulat Aweke,Ahmed Y Azzam,Wondu Feyisa Feyisa Balcha,Afisu Basiru,Nebiyou Simegnew Bayileyegn
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:27 (10): 1314-1340
标识
DOI:10.1016/s1470-2045(26)00291-3
摘要

BACKGROUND: Cancer remains a leading cause of death and disability worldwide, with a disproportionately rising burden across Africa. Effective policy responses have been consistently hampered by fragmented and incomplete cancer surveillance data. Using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, we estimated the burden of 48 cancer types across all 54 African countries over the period 1990 to 2023. These age-disaggregated and sex-disaggregated findings provide a crucial empirical foundation to inform regional control strategies and monitor progress towards global health targets. METHODS: We applied GBD 2023 methodology to estimate fatal and non-fatal outcomes of cancer alongside risk-attributable burden from 88 modifiable risk factors, across all 54 African countries. The estimation of cancer burden attributable to risk factors followed the comparative risk assessment framework. Estimates of incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) were stratified by age, sex, location, and year (1990-2023) and reported as counts and age-standardised rates per 100 000 population. Mean estimates represent the mean across 250 draws, with 95% uncertainty intervals calculated from the 2·5th and 97·5th percentiles. FINDINGS: In 2023, cancer, including non-melanoma skin cancer, accounted for an estimated 1·54 million (95% uncertainty interval 1·37-1·75) incident cases, 923 000 (824 000-1 020 000) deaths, and 33·9 million (30·6-37·1) DALYs across all ages and both sexes in Africa, of which 98·2% (97·9-98·3) were attributable to YLLs. In Africa, 10·7 million (8·9-12·9) DALYs and 306 000 (254 000-363 000) cancer deaths in 2023 were attributable to the 88 risk factors assessed in GBD 2023, equivalent to 31·6% (26·8-35·9) of total DALYs and 33·1% (28·7-37·2) of total cancer deaths across all ages and both sexes. Between 1990 and 2023, deaths attributable to risk factors increased by 216·0% (159·3-284·5) for both sexes combined. In 2023, incident cancer cases in females numbered 960 000 (821 000-1 130 000), with breast and cervical cancers together accounting for 53·5% (44·7-62·2) of all female incident cases. In males, prostate, liver, tracheal, bronchus and lung, and colorectal cancers were the leading types, together accounting for 44·8% (36·2-54·3) of all male cancers in Africa in 2023. Childhood cancer (ages 0-19 years) in Africa accounted for 104 000 (84 600-130 000) incident cases and 54 700 (47 500-64 500) deaths, representing 27·7% (26·6-29·4) of global incidence and 38·0% (36·3-40·0) of global deaths in 2023. Cancers in adolescents and young adults (ages 15-39 years) contributed 26·6% (26·4-27·5) of total cancer DALYs in Africa, those in older adults aged 40-64 years contributed 44·8% (43·8-45·6), and those in adults aged 65 years and older contributed 18·3% (17·4-19·1). INTERPRETATION: Cancer is a growing contributor to the disease burden in Africa, with rising cases, deaths, and DALYs disproportionately affecting children, adolescents, and young adults. The increase in age-standardised mortality and DALY rates stands in sharp contrast to the ambitions of the Sustainable Development Goals for 2030 and the African Union Agenda 2063. Addressing this burden will require coordinated national and international action, with health-system strengthening and context-specific cancer-control strategies spanning prevention, early diagnosis, and treatment. FUNDING: Gates Foundation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Anla完成签到,获得积分10
2秒前
4秒前
5秒前
agnway完成签到,获得积分10
7秒前
搞怪的老九的应助被涵泽采纳,获得10
7秒前
lidocaine完成签到 ,获得积分10
8秒前
para完成签到,获得积分10
10秒前
肖肖发布了新的文献求助10
10秒前
xi完成签到 ,获得积分10
10秒前
11秒前
山茶花开完成签到,获得积分10
11秒前
希望天下0贩的0的应助被Sissi采纳,获得10
11秒前
欢呼凝海完成签到 ,获得积分10
14秒前
科研通AI2S的应助被神勇的筝采纳,获得30
14秒前
zzjj完成签到 ,获得积分10
16秒前
19秒前
21秒前
22秒前
maki完成签到,获得积分10
25秒前
q2026完成签到 ,获得积分20
25秒前
123完成签到,获得积分10
26秒前
缓慢的秋荷完成签到,获得积分10
26秒前
Laluna的应助被suicone采纳,获得10
27秒前
巨型肥猫发布了新的文献求助10
27秒前
31秒前
31秒前
肉袒牵洋完成签到 ,获得积分10
34秒前
欢喜的不尤完成签到,获得积分10
35秒前
神勇的筝发布了新的文献求助30
36秒前
bkagyin的应助被兴奋小蚂蚁采纳,获得10
37秒前
37秒前
38秒前
39秒前
whs关闭了whs的文献求助
41秒前
DOC_XIONG的应助被涵泽采纳,获得10
46秒前
47秒前
yangyang完成签到 ,获得积分10
47秒前
沉静代秋完成签到,获得积分20
47秒前
sss完成签到 ,获得积分10
48秒前
可靠的公爵熊完成签到,获得积分10
51秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179656
求助须知:如何正确求助?哪些是违规求助? 9569921
关于积分的说明 21807706
捐赠科研通 7775141
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478778